SGCM
IBB icon

Sanchez Gaunt Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Sanchez Gaunt Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Sell
8,368
-178
-2% -$30.6K 0.89% 28
2026
Q1 		$1.44M Buy
+8,546
New +$1.46M 0.9% 27

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Sanchez Gaunt Capital Management's IBB Position: Q2 2026 in Review

Sanchez Gaunt Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 2.1% in Q2 2026, selling an estimated $30.6K and leaving 8,368 shares worth $1.59M. The position accounts for 0.89% of the portfolio, ranked #28.

Sanchez Gaunt Capital Management first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. 953 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Sanchez Gaunt Capital Management held 8,368 shares of iShares Biotechnology ETF worth $1.59M as of Q2 2026.
  • Sanchez Gaunt Capital Management sold 178 iShares Biotechnology ETF shares in Q2 2026, an estimated $30.6K.
  • iShares Biotechnology ETF made up 0.89% of Sanchez Gaunt Capital Management's portfolio in Q2 2026, its #28 holding.
  • Sanchez Gaunt Capital Management first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • 953 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Sanchez Gaunt Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.